Ce diaporama a bien été signalé.
Nous utilisons votre profil LinkedIn et vos données d’activité pour vous proposer des publicités personnalisées et pertinentes. Vous pouvez changer vos préférences de publicités à tout moment.

Vosti - Nutrition

Vosti - Nutrition

  • Soyez le premier à commenter

  • Soyez le premier à aimer ceci

Vosti - Nutrition

  1. 1. Preventive Nutrition Interventions Reina Engle-Stone, Christine P Stewart, Hanqi Luo, Stephen A Vosti, Katie Adams University of California, Davis Haiti Priorise conference, April 28-May 3, 2017
  2. 2. Inadequate micronutrient nutrition affects health and development • Women of reproductive age and young children are most vulnerable • Anemia in pregnancy (53.9% in Haiti) is associated with increased risk of infant mortality, and preterm birth and low birth weight (which have long term consequences for infant) • Calcium supplementation to pregnant women reduces the risk of pre-eclampsia, which increases risk of maternal mortality. • Sufficient folic acid at the time of conception reduces the risk of neural tube defects (500+ cases/year in Haiti), which are usually either fatal or result in severe disability. • Fortification delivers folic acid early enough to reduce NTDs • Consistent reductions in NTDs observed following folic acid fortification in other countries
  3. 3. Inadequate micronutrient nutrition affects health and development • Anemia prevalence in Haiti • 45.3% (rural) to 53.9% (urban) among women of reproductive age • 64.5% (rural) to 66.0% (urban) among preschool children • 50% of anemia assumed to be caused by iron deficiency • Programs to increase iron intake (food fortification, supplements) reduce the risk of iron deficiency anemia Summary: high burden of death and disability from micronutrient deficiencies
  4. 4. Multiple micronutrient and calcium supplements delivered to pregnant women
  5. 5. Micronutrient malnutrition in pregnancy: There are interventions that work • Iron folic acid supplements (vs. placebo) during pregnancy reduce the risk of anemia by 64% and low birth weight by 16% • Multiple micronutrient supplements (vs. IFA) during pregnancy reduce the risk of stillbirth by 8% and low birth weight by 12% • Calcium supplements (vs. placebo) during pregnancy reduce the risk of maternal mortality by 20%, preeclampsia by 55%, and preterm birth by 24%
  6. 6. Maternal supplementation with multiple micronutrients and calcium during pregnancy • Provision of multiple micronutrient supplements and calcium supplements to pregnant women • Daily supplements for 8 months; supplement bottles provided every 2 months • Delivered through antenatal care system. Current ANC coverage (DHS 2012) Any coverage (≥1 visit) WHO recommended coverage (≥4 visits) Urban 93% 74% Rural 90% 60%
  7. 7. Costs of supplement distribution • Startup costs • Training all existing ANC staff • Hiring additional staff to cover added workload for supplement delivery (estimated at ~10 min per pregnant woman per 2 mo) • Development of social marketing campaign for use in ANC facilities to promote MN supplements 0% 20% 40% 60% 80% 100% 2017 2022 2027 Year Coverage (% of optimal visits achieved) • Recurring costs • Tablet costs, storage, and transport • Refresher trainings, new trainings due to staff turnover • Rural area outreach to catch women missed by the ANC system • Supervision
  8. 8. Benefits of supplementation during pregnancy • DALYs averted • Deaths avoided • Maternal deaths due to pre-eclampsia (168 in Y1  235 in Y12) • Stillbirths (287 in Y1  403 in Y12) • Preterm birth (567 in Y1  796 in Y12) • Disability avoided • Maternal anemia cases (85,000 in Y1  119,000 in Y12) • Low birth weight (13,000 in Y1  19,000 in Y12) • Preterm birth (8,000 in Y1  11,000 in Y12) • Productivity losses avoided due to low birthweight reduction
  9. 9. Total benefits, total costs, and cost-benefit ratios Valuation of DALYs Discount Rate Benefit (in Gourdes) Cost (in Gourdes) BCR 3 X GDP 5% 79,844,981,881 7,637,956,645 10 Sensitivity analyses showed that greater coverage associated with greater BCR
  10. 10. Wheat flour fortification with iron and folic acid
  11. 11. Addition of iron and folic acid to industrially produced wheat flour • Flour fortification programs being scaled up globally  growing experience in implementation in LMICs • Wheat is imported and milled in Haiti (centralized/few millers; small % imported as wheat flour) • Concentrated micronutrient premix mixed into flour • Reaches all consumers of wheat flour (41% urban, 34% rural) • Reach estimated from ECVMAS household survey data (defined as households purchasing bread 3-4 times in past week) 0% 50% 100% 2017 2022 2027 % of flour adequately fortified  % of flour adequately fortified is assumed to scale up gradually to 95% beginning in year 6
  12. 12. Costs of wheat flour fortification • Startup costs • 47,214,375 Gourdes in Y1 • Equipment • Micronutrient survey • Revisiting norms • Recurring costs • 42,417,810 Gourdes in Y12) • Micronutrient premix (90+% of annual costs in Year 12) • Monitoring and evaluation • Additional periodic costs included to replace equipment and conduct evaluation surveys 0 20,000,000 40,000,000 60,000,000 80,000,000 2017 2022 2027 Program cost, Gourdes per year
  13. 13. Benefits: DALYs averted • Decrease in deaths due to neural tube defects by folic acid • Decrease in iron deficiency anemia • Women of reproductive age (15-49 y) • School age children (5-14 y) • Preschool children (6mo-4 y) After scaling up to 95% fortified: • 140+ cases of neural tube defects averted annually (assume 100% mortality) • Number of cases of anemia averted annually (1 year duration) • 92,000+ women • 100,000+ school-age children • 61,000+ preschool children 0 5000 10000 15000 20000 25000 30000 35000 Anemia, women Anemia, school age children Anemia, preschool children Deaths, neural tube defects Total DALYs over 12 y, 3% discount
  14. 14. Total benefits, total costs, and cost-benefit ratios Valuation of DALYs Discount Rate Benefit (in Gourdes) Cost (in Gourdes) BCR 3 X GDP 5% 7,938,064,315 331,312,834 24 Sensitivity analyses showed favorable BCRs even if reductions in iron deficiency anemia among children are not included (e.g., if young children eat less wheat flour than assumed)
  15. 15. Micronutrient powder distribution to children 6-23 months of age
  16. 16. Micronutrient powders (MNP) • Micronutrient powder sachets = “home fortification” • WHO guideline recommends delivery to children 6-23 months for reduction of anemia • 2 doses per year; 1 dose=2 months of daily sachets • We assumed “passive” distribution at health clinics and rally posts • Relies on caregiver to visit clinic to receive sachets • Use vaccination rates as proxy for % of children who would receive MNP More intensive distribution would have greater costs and greater benefits.
  17. 17. Costs of distribution of MNP though health centers • Startup • Train all health workers • Recurring • Additional health workers needed: Assumes 2 visits per year and 15 min/visit to provide instructions on MNP use • Periodic retraining of health workers • Supervision • MNP procurement (product, transportation, storage) 0% 10% 20% 30% 40% 50% 60% 2017 2022 2027 year Coverage % receiving all 8 vaccines % receiving MNP • Main cost after startup is MNP itself • ~75+% of total cost, assuming $0.017/sachet, and 2 courses of 60 sachets each  ~$2/child/year
  18. 18. DALYs averted by anemia reduction in children 6-23 months • MNP include multiple micronutrients (iron, zinc, vitamin A), but impact on anemia thought to be due mainly to reduction in iron deficiency anemia • 44% reduction in anemia observed in study in Haiti (cluster randomized pre-post intervention design: Menon et al., 2007) • [For comparison: 31% reduction in anemia estimated by meta- analysis of 6 trials (WHO, 2011)] • Assuming program reaches full scale up by year 8 (all children who receive vaccines also get MNP), • 58,000+ cases of anemia averted annually beginning Year 8
  19. 19. Total benefits, total costs, and cost-benefit ratios Valuation of DALYs Discount Rate Benefit (in Gourdes) Cost (in Gourdes) BCR 3 X GDP 5% 1,200,675,600 157,324,005 8 Benefits are sensitive to cost of MNP product; less sensitive to achieved coverage

×